Casdin Capital, LLC
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1534261
New York, NY
Position in BBOT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,526,692
-$1,007,854 QoQ
Shares Held
282,312
0.0% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#24
of 67 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBOT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $705,487,766 across 26 Biotechnology names. BBOT ranks #22 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $250,645,634 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
14,418,574 | $143,464,811 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $56,635,000 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
1,840,000 | $35,328,000 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $32,170,500 | |
| 6 | NGNE |
Neurogene Inc.
|
1,420,361 | $28,634,477 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,000 | $24,815,250 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
758,857 | $22,651,881 |
All Filings in BBOT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,526,692 | 282,312 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,534,546 | 282,312 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,269,172 | 282,312 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||